Schmidhofer, Sandra
University Hospital Regensburg · AstraZeneca (Germany)
4 papers on CoChat
Most cited papers
- Verified
Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1
Minderjahn, J., Schmidt, A., Fuchs, A., Schill, R., Raithel, J., Babina, M., Schmidl, C., Gebhard, C., Schmidhofer, S., Mendes, K., et al. (2020) · Nature Communications
Genomics and Chromatin DynamicsChromatin Remodeling and Cancer
Cited by 136
- Verified
Mechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU.1
Pham, T.-H., Minderjahn, J., Schmidl, C., Hoffmeister, H., Schmidhofer, S., Chen, W., Längst, G., Benner, C., & Rehli, M. (2013) · Nucleic Acids Research
Genomics and Chromatin DynamicsEpigenetics and DNA Methylation
Cited by 102
- Verified
5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes
Klug, M., Schmidhofer, S., Gebhard, C., Andreesen, R., & Rehli, M. (2013) · Genome Biology
Epigenetics and DNA MethylationGenomics and Chromatin Dynamics
Cited by 101
- Verified
Author Correction: Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1
Minderjahn, J., Schmidt, A., Fuchs, A., Schill, R., Raithel, J., Babina, M., Schmidl, C., Gebhard, C., Schmidhofer, S., Mendes, K., et al. (2020) · Nature Communications
Genomics and Chromatin DynamicsEpigenetics and DNA Methylation
Cited by 3
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free